Lisa A. Ford

426 total citations
12 papers, 273 citations indexed

About

Lisa A. Ford is a scholar working on Molecular Biology, Clinical Biochemistry and Nephrology. According to data from OpenAlex, Lisa A. Ford has authored 12 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Clinical Biochemistry and 2 papers in Nephrology. Recurrent topics in Lisa A. Ford's work include Metabolomics and Mass Spectrometry Studies (8 papers), Metabolism and Genetic Disorders (4 papers) and Analytical Chemistry and Chromatography (2 papers). Lisa A. Ford is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (8 papers), Metabolism and Genetic Disorders (4 papers) and Analytical Chemistry and Chromatography (2 papers). Lisa A. Ford collaborates with scholars based in United States and Iceland. Lisa A. Ford's co-authors include Douglas R. Toal, Anne M. Evans, Kelli D. Goodman, Adam D. Kennedy, Jacob Wulff, Luke A. D. Miller, Kirk L. Pappan, Sarah H. Elsea, John J. Lennon and Qibo Zhang and has published in prestigious journals such as PLoS ONE, Cancer and Clinical Chemistry.

In The Last Decade

Lisa A. Ford

11 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lisa A. Ford United States	9	133	55	48	37	33	12	273
Régis Périchon United States	10	193 1.5×	97 1.8×	52 1.1×	32 0.9×	91 2.8×	11	422
Kelli D. Goodman United States	6	112 0.8×	52 0.9×	38 0.8×	35 0.9×	31 0.9×	9	218
Dominique M. Bovée Netherlands	11	158 1.2×	40 0.7×	91 1.9×	8 0.2×	32 1.0×	15	438
Akinori Yuri Japan	3	206 1.5×	131 2.4×	133 2.8×	16 0.4×	33 1.0×	4	346
Anna V. Oláh Hungary	11	123 0.9×	40 0.7×	28 0.6×	26 0.7×	14 0.4×	41	311
Andreas Entenmann Austria	11	101 0.8×	46 0.8×	13 0.3×	23 0.6×	108 3.3×	31	328
Heike Dombrowsky Germany	10	109 0.8×	34 0.6×	9 0.2×	18 0.5×	25 0.8×	15	334
Peter Sizeland New Zealand	8	76 0.6×	47 0.9×	15 0.3×	70 1.9×	19 0.6×	10	317
Julia Wenger United States	7	257 1.9×	68 1.2×	53 1.1×	57 1.5×	47 1.4×	9	346
Elise Lombard France	7	71 0.5×	204 3.7×	50 1.0×	11 0.3×	13 0.4×	9	378

Countries citing papers authored by Lisa A. Ford

Since Specialization

Citations

This map shows the geographic impact of Lisa A. Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa A. Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa A. Ford more than expected).

Fields of papers citing papers by Lisa A. Ford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa A. Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa A. Ford. The network helps show where Lisa A. Ford may publish in the future.

Co-authorship network of co-authors of Lisa A. Ford

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa A. Ford. A scholar is included among the top collaborators of Lisa A. Ford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa A. Ford. Lisa A. Ford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Polanco, Patricio M., Tamas A. Gonda, Erkut Borazanci, et al.. (2025). Confirmatory Clinical Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma. Current Oncology. 32(11). 638–638.

Ford, Lisa A., Matthew Mitchell, Jacob Wulff, et al.. (2022). Clinical metabolomics for inborn errors of metabolism. Advances in clinical chemistry. 107. 79–138. 7 indexed citations

Goodman, Kelli D., Matthew Mitchell, Anne M. Evans, et al.. (2021). Assessment of the effects of repeated freeze thawing and extended bench top processing of plasma samples using untargeted metabolomics. Metabolomics. 17(3). 31–31. 13 indexed citations

Kennedy, Adam D., Lisa A. Ford, Bryan M. Wittmann, et al.. (2021). Global biochemical analysis of plasma, serum and whole blood collected using various anticoagulant additives. PLoS ONE. 16(4). e0249797–e0249797. 19 indexed citations

Ford, Lisa A., Adam D. Kennedy, Kelli D. Goodman, et al.. (2020). Precision of a Clinical Metabolomics Profiling Platform for Use in the Identification of Inborn Errors of Metabolism. The Journal of Applied Laboratory Medicine. 5(2). 342–356. 116 indexed citations

Freed, Tiffany A., Josef Coresh, Lesley A. Inker, et al.. (2019). Validation of a Metabolite Panel for a More Accurate Estimation of Glomerular Filtration Rate Using Quantitative LC-MS/MS. Clinical Chemistry. 65(3). 406–418. 17 indexed citations

Coresh, Josef, Lesley A. Inker, Yingying Sang, et al.. (2018). Metabolomic profiling to improve glomerular filtration rate estimation: a proof-of-concept study. Nephrology Dialysis Transplantation. 34(5). 825–833. 38 indexed citations

Zhang, Qibo, Lisa A. Ford, Anne M. Evans, & Douglas R. Toal. (2018). Identification of an Endogenous Organosulfur Metabolite by Interpretation of Mass Spectrometric Data. Organic Letters. 20(7). 2100–2103. 7 indexed citations

Zhang, Qibo, Lisa A. Ford, Anne M. Evans, & Douglas R. Toal. (2017). Structure elucidation of metabolite x17299 by interpretation of mass spectrometric data. Metabolomics. 13(8). 92–92. 20 indexed citations

10.

Zhang, Qibo, et al.. (2016). LC–MS/MS method for quantitation of seven biomarkers in human plasma for the assessment of insulin resistance and impaired glucose tolerance. Journal of Chromatography B. 1038. 101–108. 12 indexed citations

11.

McDunn, Jonathan E., Steven M. Stirdivant, Lisa A. Ford, & Robert L. Wolfert. (2015). Metabolomics and its Application to the Development of Clinical Laboratory Tests for Prostate Cancer.. PubMed. 26(2). 92–104. 8 indexed citations

12.

Boublik, Martin, et al.. (1992). Functional outcome of pathologic fracture secondary to malignant disease in a rehabilitation hospital. Cancer. 69(1). 98–102. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact